Fatal human anaplasmosis associated with macrophage activation syndrome in Greece and the Public Health response

J Infect Public Health. 2017 Nov-Dec;10(6):819-823. doi: 10.1016/j.jiph.2017.01.002. Epub 2017 Feb 8.

Abstract

Human granulocytic anaplasmosis (HGA) is a tick-borne disease caused by Anaplasma phagocytophilum that has the potential to spread in new geographical areas. The first fatal case of HGA in Greece is presented. Fever of unknown origin, renal and respiratory insufficiency and development of macrophage activation syndrome characterized the clinical presentation. Amplification and sequencing of a fragment of the groEL gene revealed the presence of A. phagocytophilum. The epidemiological and clinical features were collected during an epidemiological investigation. Public health measures were instituted by the Hellenic Centre for Disease Control and Prevention. The Public Health intervention required the collaboration of epidemiologists, veterinarians and microbiologists. Emphasis was given to communication activities and misconceptions concerning canines and their role in the disease. The emergence of human anaplasmosis in a new geographical area highlights the importance of disease awareness and of the need for continued support for tick and tick-borne disease surveillance networks.

Keywords: Anaplasma; Anaplasma phagocytophilum; Granulocytic anaplasmosis; Greece.

Publication types

  • Case Reports

MeSH terms

  • Anaplasma phagocytophilum / isolation & purification*
  • Anaplasmosis / complications*
  • Anaplasmosis / diagnosis*
  • Anaplasmosis / pathology
  • Animals
  • Dogs
  • Fatal Outcome
  • Greece
  • Humans
  • Macrophage Activation Syndrome / diagnosis*
  • Macrophage Activation Syndrome / pathology*
  • Male
  • Middle Aged
  • Public Health Administration